-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Galera Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q2 2024.
- Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $723K, a 52.6% decline year-over-year.
- Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.18M, a 35.5% decline year-over-year.
- Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.56M, a 22.4% decline from 2022.
- Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.16M, a 0.93% decline from 2021.
- Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.23M, a 30.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)